Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction

GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation Systems, Infusion Systems and Others” provides key market data on the Belgium Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories – Inhalation Systems, Needle Free Injections and Infusion Systems. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Inhalation Systems, Needle Free Injections and Infusion Systems.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others.
- 2009 company shares and distribution shares data for each of the three market categories.
- Global corporate-level profiles of key companies operating within the Belgium Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca International plc, Boehringer Ingelheim GmbH, Sepracor Inc., CareFusion Corporation and others.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Explore investment opportunites in the market.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
GlaxoSmithKline plc
AstraZeneca PLC
Novartis Medical Nutrition
Boehringer Ingelheim GmbH
Baxter International Inc.
3M Health Care
Smiths Medical
B. Braun Melsungen AG
Cardinal Health, Inc.
Hospira, Inc.
Terumo Corporation
NIPRO CORPORATION
Fresenius Kabi AG
CareFusion Corporation
[Studien Infos ausblenden]

TABLE OF CONTENTS

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What is This Report About? 8
3 Drug Delivery Devices In Belgium 9
3.1 Drug Delivery Devices, Market Segmentation 9
3.2 Drug Delivery Devices, Belgium, Overall Revenue ($m), 2002-2016 10
3.3 Drug Delivery Devices Market, Belgium, Revenue Mix ($m), 2009 11
3.4 Drug Delivery Devices Market, Belgium, Category Contribution (%), 2009 12
3.5 Drug Delivery Devices, Belgium, Category Volume (Units), 2002-2016 16
3.6 Drug Delivery Devices, Belgium, Company Share (2008-2009) 19
4 Infusion Systems In Belgium 21
4.1 Infusion Systems, Market Segmentation 21
4.2 Infusion Systems Market, Belgium, Revenue Mix ($m), 2009 22
4.3 Infusion Systems Market, Belgium, Segment Contribution (%), 2009 23
4.4 Infusion Systems Overall Revenue (2002-2016) 24
4.5 Infusion Systems Overall Volume (2002-2016) 28
4.6 Infusion Systems Average Price (2002-2016) 32
4.7 Infusion Systems Distribution Share (2008-2009) 33
4.8 Infusion Systems, Belgium, Company Share (2008-2009) 34
5 Inhalation Systems In Belgium 36
5.1 Inhalation Systems, Market Segmentation 36
5.2 Inhalation Systems Market, Belgium, Revenue Mix ($m), 2009 37
5.3 Inhalation Systems Market, Belgium, Segment Contribution (%), 2009 38
5.4 Inhalation Systems Overall Revenue (2002-2016) 39
5.5 Inhalation Systems Overall Volume (2002-2016) 43
5.6 Inhalation Systems Average Price (2002-2016) 46
5.7 Inhalation Systems Distribution Share (2008-2009) 47
5.8 Inhalation Systems, Belgium, Company Share (2008-2009) 48
6 Overview of Key Companies in Belgium Drug Delivery Devices Market 50
6.1 GlaxoSmithKline plc 50
6.1.1 Company Overview 50
6.1.2 Share in the Belgium Drug Delivery Devices Market 50
6.2 AstraZeneca PLC 51
6.2.1 Company Overview 51
6.2.2 Share in the Belgium Drug Delivery Devices Market 52
6.3 Novartis Medical Nutrition 53
6.3.1 Company Overview 53
6.3.2 Share in the Belgium Drug Delivery Devices Market 54
6.4 Boehringer Ingelheim GmbH 55
6.4.1 Company Overview 55
6.4.2 Share in the Belgium Drug Delivery Devices Market 56
6.5 Baxter International Inc. 57
6.5.1 Company Overview 57
6.5.2 Share in the Belgium Drug Delivery Devices Market 57
6.6 3M Health Care 58
6.6.1 Company Overview 58
6.6.2 Share in the Belgium Drug Delivery Devices Market 58
6.7 Smiths Medical 59
6.7.1 Company Overview 59
6.8 B. Braun Melsungen AG 59
6.8.1 Company Overview 59
6.9 Cardinal Health, Inc. 59
6.9.1 Company Overview 59
6.10 Hospira, Inc. 60
6.10.1 Company Overview 60
6.11 Terumo Corporation 60
6.11.1 Company Overview 60
6.12 NIPRO CORPORATION 60
6.12.1 Company Overview 60
6.13 Fresenius Kabi AG 61
6.13.1 Company Overview 61
6.14 CareFusion Corporation 61
6.14.1 Company Overview 61
7 Drug Delivery Devices Market Pipeline Products 62
8 Appendix 68
8.1 Definitions of Markets Covered in the Report 69
8.1.1 Drug Delivery Devices 69
8.2 Research Methodology 70
8.3 Secondary Research 70
8.4 Primary Research 71
8.5 Models 71
8.6 Forecasts 72
8.7 Expert Panels 72
8.8 GlobalData Consulting 72
8.9 Currency Conversion 72
8.10 Contact Us 73
8.11 Disclaimer 73
[Inhaltsverzeichnis ausblenden]

LIST OF TABLES

1.1 List of Tables
Table 1: Drug Delivery Devices, Belgium, Overall Revenue ($m), 2002-2016 10
Table 2: Drug Delivery Devices Market, Belgium, Category Contribution (%), 2009 12
Table 3: Drug Delivery Devices, Belgium, Cross-Segment Analysis, 2002-2016 13
Table 4: Drug Delivery Devices, Belgium, Overall Revenue ($m), Historic, 2002-2009 14
Table 5: Drug Delivery Devices, Belgium, Overall Revenue ($m), Forecast, 2009-2016 15
Table 6: Drug Delivery Devices, Belgium, Category Volume (Units), 2002-2016 16
Table 7: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2002-2009 17
Table 8: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2009-2016 18
Table 9: Drug Delivery Devices, Belgium, Company Share by Revenue ($m), 2008-2009 20
Table 10: Infusion Systems Market, Belgium, Segment Contribution (%), 2009 23
Table 11: Infusion Systems, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 25
Table 12: Infusion Systems, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 27
Table 13: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2002-2009 29
Table 14: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 31
Table 15: Infusion Systems, Belgium, Average Price ($), Historic, 2002-2009 32
Table 16: Infusion Systems, Belgium, Average Price ($), Forecast, 2009-2016 32
Table 17: Infusion Systems, Belgium, Distribution Share by Revenue ($m), 2008-2009 33
Table 18: Infusion Systems, Belgium, Company Share by Revenue ($m), 2008-2009 35
Table 19: Inhalation Systems Market, Belgium, Segment Contribution (%), 2009 38
Table 20: Inhalation Systems, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 40
Table 21: Inhalation Systems, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 42
Table 22: Inhalation Systems, Belgium, Volume (Units) by Segment, Historic, 2002-2009 44
Table 23: Inhalation Systems, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 45
Table 24: Inhalation Systems, Belgium, Average Price ($), Historic, 2002-2009 46
Table 25: Inhalation Systems, Belgium, Average Price ($), Forecast, 2009-2016 46
Table 26: Inhalation Systems, Belgium, Distribution Share by Revenue ($m), 2008-2009 47
Table 27: Inhalation Systems, Belgium, Company Share by Revenue ($m), 2008-2009 49
Table 28: Drug Delivery Devices Market Pipeline Products 62
Table 29: USD to Local Currency, Belgium, Average Actual Rate 2002-2009 72
LIST OF FIGURES

1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 9
Figure 2: Drug Delivery Devices, Belgium, Overall Revenue ($m), 2002-2016 10
Figure 3: Drug Delivery Devices Market, Belgium, Revenue Mix ($m), 2009 11
Figure 4: Drug Delivery Devices Market, Belgium, Category Contribution (%), 2009 12
Figure 5: Drug Delivery Devices Market, Belgium, Cross-Segment Analysis, 2002-2016 13
Figure 6: Drug Delivery Devices, Belgium, Overall Revenue ($m), Historic, 2002-2009 14
Figure 7: Drug Delivery Devices, Belgium, Overall Revenue ($m), Forecast, 2009-2016 15
Figure 8: Drug Delivery Devices, Belgium, Category Volume (Units), 2002-2016 16
Figure 9: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2002-2009 17
Figure 10: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2009-2016 18
Figure 11: Drug Delivery Devices, Belgium, Company Share (%), 2009 19
Figure 12: Infusion Systems, Market Segmentation 21
Figure 13: Infusion Systems Market, Belgium, Revenue Mix ($m), 2009 22
Figure 14: Infusion Systems Market, Belgium, Segment Contribution (%), 2009 23
Figure 15: Infusion Systems, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 24
Figure 16: Infusion Systems, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 26
Figure 17: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2002-2009 28
Figure 18: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 30
Figure 19: Infusion Systems, Belgium, Company Share (%), 2009 34
Figure 20: Inhalation Systems, Market Segmentation 36
Figure 21: Inhalation Systems Market, Belgium, Revenue Mix ($m), 2009 37
Figure 22: Inhalation Systems Market, Belgium, Segment Contribution (%), 2009 38
Figure 23: Inhalation Systems, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 39
Figure 24: Inhalation Systems, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 41
Figure 25: Inhalation Systems, Belgium, Volume (Units) by Segment, Historic, 2002-2009 43
Figure 26: Inhalation Systems, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 45
Figure 27: Inhalation Systems, Belgium, Company Share (%), 2009 48
Figure 28: GlaxoSmithKline plc, Company Share (%), Belgium Drug Delivery Devices Market, 2009 50
Figure 29: AstraZeneca PLC, Company Share (%), Belgium Drug Delivery Devices Market, 2009 52
Figure 30: Novartis Medical Nutrition Company Share (%), Belgium Drug Delivery Devices Market, 2009 54
Figure 31: Boehringer Ingelheim GmbH, Company Share (%), Belgium Drug Delivery Devices Market, 2009 56
Figure 32: Baxter International Inc., Company Share (%), Belgium Drug Delivery Devices Market, 2009 57
Figure 33: 3M Health Care, Company Share (%), Belgium Drug Delivery Devices Market, 2009 58
[Tabellenverzeichnis ausblenden]